These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9762665)

  • 1. Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide.
    Laman JD; Maassen CB; Schellekens MM; Visser L; Kap M; de Jong E; van Puijenbroek M; van Stipdonk MJ; van Meurs M; Schwärzler C; Günthert U
    Mult Scler; 1998 Jun; 4(3):147-53. PubMed ID: 9762665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.
    Gerritse K; Laman JD; Noelle RJ; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
    Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2499-504. PubMed ID: 8637903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.
    Howard LM; Miga AJ; Vanderlugt CL; Dal Canto MC; Laman JD; Noelle RJ; Miller SD
    J Clin Invest; 1999 Jan; 103(2):281-90. PubMed ID: 9916140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis.
    Howard LM; Ostrovidov S; Smith CE; Dal Canto MC; Miller SD
    J Clin Invest; 2002 Jan; 109(2):233-41. PubMed ID: 11805135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells.
    Ghazi-Visser L; Laman JD; Nagel S; van Meurs M; van Riel D; Tzankov A; Frank S; Adams H; Wolk K; Terracciano L; Melief MJ; Sabat R; Günthert U
    FASEB J; 2013 Sep; 27(9):3683-701. PubMed ID: 23752202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FcR interactions do not play a major role in inhibition of experimental autoimmune encephalomyelitis by anti-CD154 monoclonal antibodies.
    Nagelkerken L; Haspels I; van Rijs W; Blauw B; Ferrant JL; Hess DM; Garber EA; Taylor FR; Burkly LC
    J Immunol; 2004 Jul; 173(2):993-9. PubMed ID: 15240687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
    J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses.
    Blazar BR; Taylor PA; Noelle RJ; Vallera DA
    J Clin Invest; 1998 Aug; 102(3):473-82. PubMed ID: 9691083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting kallikrein 6 proteolysis attenuates CNS inflammatory disease.
    Blaber SI; Ciric B; Christophi GP; Bernett MJ; Blaber M; Rodriguez M; Scarisbrick IA
    FASEB J; 2004 May; 18(7):920-2. PubMed ID: 15033932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
    J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo.
    Issazadeh S; Navikas V; Schaub M; Sayegh M; Khoury S
    J Immunol; 1998 Aug; 161(3):1104-12. PubMed ID: 9686568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium smegmatis expressing a chimeric protein MPT64-proteolipid protein (PLP) 139-151 reorganizes the PLP-specific T cell repertoire favoring a CD8-mediated response and induces a relapsing experimental autoimmune encephalomyelitis.
    Nicolò C; Sali M; Di Sante G; Geloso MC; Signori E; Penitente R; Uniyal S; Rinaldi M; Ingrosso L; Fazio VM; Chan BM; Delogu G; Ria F
    J Immunol; 2010 Jan; 184(1):222-35. PubMed ID: 19949067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a continued requirement for CD40/CD40 ligand (CD154) interactions in the progression of LP-BM5 retrovirus-induced murine AIDS.
    Green KA; Noelle RJ; Green WR
    Virology; 1998 Feb; 241(2):260-8. PubMed ID: 9499800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
    Whitham RH; Kotzin BL; Buenafe AC; Weinberg AD; Jones RE; Hashim GA; Hoy CM; Vandenbark AA; Offner H
    J Neurosci Res; 1993 Jun; 35(2):115-28. PubMed ID: 7686583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions.
    Sobel RA; Kuchroo VK
    J Immunol; 1992 Aug; 149(4):1444-51. PubMed ID: 1380045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
    Jaiswal AI; Croft M
    J Immunol; 1997 Sep; 159(5):2282-91. PubMed ID: 9278317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40L is necessary for the priming of effector cells for lymphocytic and granulomatous experimental autoimmune thyroiditis.
    Peterson KE; Braley-Mullen H
    J Autoimmun; 1999 Feb; 12(1):1-12. PubMed ID: 10028017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
    Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
    Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12 reverses the suppressive effect of the CD40 ligand blockade on experimental autoimmune encephalomyelitis (EAE).
    Constantinescu CS; Hilliard B; Wysocka M; Ventura ES; Bhopale MK; Trinchieri G; Rostami AM
    J Neurol Sci; 1999 Dec; 171(1):60-4. PubMed ID: 10567051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.